InvestorsHub Logo
Post# of 252455
Next 10
Followers 13
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

Re: A deleted message

Sunday, 02/24/2019 6:37:50 PM

Sunday, February 24, 2019 6:37:50 PM

Post# of 252455
<Among the challenges confronting companies like Roche seeking to sell the new gene therapies is gaining reimbursement. Spark has said it plans to sell Luxturna in the U.S. at a cost of $850,000 a patient."

Are they totally insane?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.